A review of ceramide analogs as potential anticancer agents

Por Liu, Jiawang, Beckman, Barbara S., Foroozesh, Maryam
Publicado no Future Med Chem (2013)

MEK5/ERK5 Pathway: The first fifteen years

Por Drew, Barbara A., Burow, Matthew E., Beckman, Barbara S.
Publicado em 2011

Studies on the Mode of Action of Cholera Toxin: EFFECTS ON SOLUBILIZED ADENYLATE CYCLASE

Por Beckman, Barbara, Flores, Jorge, Witkum, Patricia A., Sharp, Geoffrey W. G.
Publicado em 1974

Dual inhibition of sphingosine kinase isoforms ablates TNF-induced drug resistance

Por ANTOON, JAMES W., WHITE, MARTIN D., BUROW, MATTHEW E., BECKMAN, BARBARA S.
Publicado em 2012

Sphingosine Kinase Isoforms as a Therapeutic Target in Endocrine Therapy Resistant Luminal and Basal-A Breast Cancer

Por Antoon, James W., White, Martin D., Driver, Jennifer L., Burow, Matthew E., Beckman, Barbara S.
Publicado em 2012

Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk

Por Beckman Barbara S, Elliott Steven, Muir Shannon E, Antoon James W, Rhodes Lyndsay V, Burow Matthew E
Publicado em 2010-11-01

Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk

Por Rhodes, Lyndsay V, Antoon, James W, Muir, Shannon E, Elliott, Steven, Beckman, Barbara S, Burow, Matthew E
Publicado em 2010

The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone

Por Williams, Christopher C., Allison, June G., Vidal, Gregory A., Burow, Matthew E., Beckman, Barbara S., Marrero, Luis, Jones, Frank E.
Publicado em 2004

Regulation of ERα-mediated transcription of Bcl-2 by PI3K-AKT crosstalk: Implications for breast cancer cell survival

Por BRATTON, MELYSSA R., DUONG, BICH N., ELLIOTT, STEVEN, WELDON, CHRISTOPHER B., BECKMAN, BARBARA S., McLACHLAN, JOHN A., BUROW, MATTHEW E.
Publicado em 2010

Targeting NFκB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2

Por Antoon, James W, White, Martin D, Slaughter, Evelyn M, Driver, Jennifer L, Khalili, Hafez S, Elliott, Steven, Smith, Charles D, Burow, Matthew E, Beckman, Barbara S
Publicado em 2011

Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer

Por Antoon, James W, Meacham, William D, Bratton, Melyssa R, Slaughter, Evelyn M, Rhodes, Lyndsay V, Ashe, Hasina B, Wiese, Thomas E, Burow, Matthew E, Beckman, Barbara S
Publicado em 2011

3-Ketone-4,6-diene ceramide analogs exclusively induce apoptosis in chemo-resistant cancer cells

Por Ponnapakam, Adharsh P., Liu, Jiawang, Bhinge, Kaustubh N., Drew, Barbara A., Wang, Tony L., Antoon, James W., Nguyen, Thong T., Dupart, Patrick S., Wang, Yuji, Zhao, Ming, Liu, Yong-Yu, Foroozesh, Maryam, Beckman, Barbara S.
Publicado em 2014

Antiestrogenic Activity of Flavonoid Phytochemicals Mediated via the c-Jun N-terminal Protein Kinase Pathway: Cell-type specific regulation of estrogen receptor alpha

Por Collins-Burow, Bridgette M., Antoon, James W., Frigo, Daniel E., Elliott, Steven, Weldon, Christopher B., Boue, Stephen M., Beckman, Barbara S., Curiel, Tyler J., Alam, Jawed, McLachlan, John A., Burow, Matthew E.
Publicado em 2012

Antiestrogenic Effects of the Novel Sphingosine Kinase-2 Inhibitor ABC294640

Por Antoon, James W., White, Martin D., Meacham, William D., Slaughter, Evelyn M., Muir, Shannon E., Elliott, Steven, Rhodes, Lyndsay V., Ashe, Hasina B., Wiese, Thomas E., Smith, Charles D., Burow, Matthew E., Beckman, Barbara S.
Publicado em 2010

Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired Chemoresistance

Por Antoon, James W., Lai, Rongye, Struckhoff, Amanda P., Nitschke, Ashley M., Elliott, Steven, Martin, Elizabeth C., Rhodes, Lyndsay V., Yoon, Nam Seung, Salvo, Virgilio A., Shan, Bin, Beckman, Barbara S., Nephew, Kenneth P., Burow, Matthew E.
Publicado em 2012

Preferential Star Strand Biogenesis of Pre-miR-24-2 Targets PKC-alpha and Suppresses Cell Survival in MCF-7 Breast Cancer Cells

Por Martin, Elizabeth C., Elliott, Steven, Rhodes, Lyndsay V., Antoon, James W., Fewell, Claire, Zhu, Yun, Driver, Jennifer L., Jodari-Karimi, Mona, Taylor, Christopher W., Flemington, Erik K., Beckman, Barbara S., Collins-Burow, Bridgette M., Burow, Matthew E.
Publicado em 2012

MEK5/ERK5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent Tumorigenesis

Por Antoon, James W., Martin, Elizabeth C., Lai, Rongye, Salvo, Virgilo A., Tang, Yan, Nitzchke, Ashley M., Elliott, Steven, Nam, Seung Yoon, Xiong, Wei, Rhodes, Lyndsay V., Collins-Burow, Bridgette, David, Odile, Wang, Guandi, Shan, Bin, Beckman, Barbara S., Nephew, Kenneth P., Burow, Matthew E.
Publicado em 2013

Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence

Por Rhodes, Lyndsay V., Muir, Shannon E., Elliott, Steven, Guillot, Lori M., Antoon, James W., Penfornis, Patrice, Tilghman, Syreeta L., Salvo, Virgilio A., Fonseca, Juan P., Lacey, Michelle R., Beckman, Barbara S., McLachlan, John A., Rowan, Brian G., Pochampally, Radhika, Burow, Matthew E.
Publicado no Breast Cancer Res Treat (2009)

Proteomic analysis of tumor necrosis factor-α resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype

Por Zhou, Changhua, Nitschke, Ashley M, Xiong, Wei, Zhang, Qiang, Tang, Yan, Bloch, Michael, Elliott, Steven, Zhu, Yun, Bazzone, Lindsey, Yu, David, Weldon, Christopher B, Schiff, Rachel, McLachlan, John A, Beckman, Barbara S, Wiese, Thomas E, Nephew, Kenneth P, Shan, Bin, Burow, Matthew E, Wang, Guangdi
Publicado em 2008

Gα(o) potentiates estrogen receptor α activity via the ERK signaling pathway

Por Bratton, Melyssa R, Antoon, James W, Duong, Bich N, Frigo, Daniel E, Tilghman, Syreeta, Collins-Burow, Bridgette M, Elliott, Steven, Tang, Yan, Melnik, Lilia I, Lai, Ling, Alam, Jawed, Beckman, Barbara S, Hill, Steven M, Rowan, Brian G, McLachlan, John A, Burow, Matthew E
Publicado em 2012